Prostate Cancer | Specialty

Dr. Sieber on the CHAARTED Trial

January 8th 2015

Paul Sieber, MD, principal investigator for clinical trials with Lancaster Urology, talks about the CHAARTED trial, which examines chemohormonal therapy versus androgen ablation for extensive disease in prostate cancer.

Medicare Reimburses 3 Prostate Cancer Diagnostic Tests

January 4th 2015

After months of delay, the Medicare Administrative Contractor (MAC), with jurisdiction over most molecular diagnostic tests used to treat cancer, made a series of decisions this fall that will allow Medicare reimbursement for several well-known tests, including 3 used in the treatment of prostate cancer.

Gene Points to Aggressive Gleason 7 Prostate Cancer

December 31st 2014

A biomarker has been found that may help determine which Gleason 7 (GS7) cancers are particularly aggressive.

There's No Place Like a Medical Home: Premier Medical Group Focuses on Full-scale Patient-Centered Care

December 28th 2014

It's not uncommon for a business to use a superlative in its name, but Premier Medical Group in Poughkeepsie, NY, truly lives up to its moniker.

No Salvage Treatment for Some With PSA Recurrence

December 27th 2014

One-third of men over 70 years of age who undergo radical prostatectomy for prostate cancer and then experience biochemical recurrence have no need for salvage treatment, according to a recent study.

Dr. Gomella on Labeling Low-Risk Prostate Cancer

December 26th 2014

Leonard Gomella, MD, urology specialist from Jefferson University, talks about the challenge of treating prostate cancer patients with a Gleason score of less than six.

Trials Show Efficacy of PARP-Targeted Agent in Prostate Cancer

December 22nd 2014

Drugs that inhibit the DNA repair enzyme poly(ADP-ribose) polymerase (PARP) have been shown to be effective in treating ovarian, breast, and prostate cancers in patients with inherited BRCA mutations. In broadening the therapeutic scope of PARP inhibitors beyond germline BRCA-mutated cancers.

Studies Find That Blood and Body Fats Drive Prostate Cancer

December 20th 2014

Fats in blood and on the body increase men's prostate cancer risk, two studies have found.

Multiparametric MRI Could Reduce Overdetection and Overtreatment in Prostate Cancer

December 20th 2014

The use of multiparametric MRI in diagnosing and treating prostate cancer was explored in November during a continuing medical education course offered at the annual meeting of LUGPA

Final Thoughts on Improving Prostate Cancer Care

December 17th 2014

Integrating a Medical Oncologist Into Urology Practices

December 17th 2014

Combination Strategies Explored in CRPC

December 17th 2014

Integrating Radium-223 Into Clinical Practice

December 17th 2014

Providing Optimal Care for Prostate Cancer

December 17th 2014

Data: The New Currency in Healthcare Improvement

December 17th 2014

Integrating Dispensing Pharmacy Services Into a Urology Group

December 17th 2014

Multiparametric MRI Biopsies: Poised for Widespread Adoption?

December 17th 2014

Multiparametric MRI for Detecting Prostate Cancer

December 17th 2014

Analyzing CTCs Using Next-Generation Sequencing

December 5th 2014

Next-Generation of CTC Technology

December 5th 2014